On 5 May 2010, the Danish Medicines Agency will perform an upgrade of the system for transmission of adverse reaction reports between the European Medicines Agency and the pharmaceutical companies (Cyklone to Axway version 5.2.2).
When the upgrade is complete, the Danish Medicines Agency will only be able to receive and dispatch reports from companies that have tested the transmission with the Danish Medicines Agency.
We kindly request companies that have not received a confirmation receipt from the Danish Medicines Agency after sending adverse reaction reports to contact us at E2B@dkma.dk. Please remember to provide details about the specific report and transmission.
For further information about the upgrade, please contact Pernille Canci Pedersen at E2B@dkma.dk or tel. +45 4488 9362.
Danish Medicines Agency, 3 May 2010